Recombinant DNA Advisory Committee - 03/1-2/93 
Steve Goff, Columbia University 
Beth Gregory, Johns Hopkins University 
Kurt Gunter, Food and Drug Administration 
Ingo Haertel, Georgetown University 
Karen Hauda, Johns Hopkins University 
Charles Hesdorffer, Columbia University 
Helen Heslop, St. Jude Childrens Research Hospital 
Tom Horiagon, Chimerix Corporation 
Zafer Iqbal, University of Illinois 
Liz Jaffae, Johns Hopkins University 
John Jaugstetter, Genentech, Inc. 
Dorothy Jessop, U.S. Department of Agriculture 
Larry Johnson, University of North Carolina, Chapel Hill 
Douglas Jolly, Viagene, Inc. 
John Kavanagh, MD Anderson Cancer Research Center 
Rachel King, Genetic Therapy, Inc. 
Don Koho, Childrens Hospital of Los Angeles 
Toshi Kotani, Genetic Therapy, Inc. 
Mike Knowles, University of North Carolina, Chapel Hill 
Maryann Krane, Genzyme Corporation 
Edward Lanphier, Somatix Corporation 
Kyle Leg g, Leg g Mason 
Ronald Leonardi, R & R Registrations 
Hy Levitsky, Johns Hopkins University 
Fray Marshall, Johns Hopkins University 
Michael McCaughan, The Blue Sheet 
Alan McClelland, Genetic Therapy, Inc. 
Gerard McGarrity, Genetic Therapy, Inc. 
Bruce Merchant, Viagene, Inc. 
Nanette Mitterder, Genetic Therapy, Inc. 
Robert Moen, Genetic Therapy, Inc. 
Lisa Morris, Genetic Therapy, Inc. 
Steve Mueller, Genetic Therapy, Inc. 
Richard Mulligan, Massachusetts Institute of Technology 
William Nelson, Johns Hopkins University 
Albert Owens, Johns Hopkins University 
Drew Pardoll, Johns Hopkins University 
Seth Pauker, Food and Drug Administration 
Steven Piantadori, Johns Hopkins University 
Rick Pickles, University of North Carolina, Chapel Hill 
Eckhard Podack, University of Miami 
Bob Powell, University of Miami 
[62] 
Recombinant DNA Research, Volume 17 
